Sign up to save your podcasts
Or
Share Lp(a) in Focus: Breakthrough Therapies and Clinical Implications
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lp(a) in Focus: Breakthrough Therapies and Clinical Implications
Elevated Lipoprotein(a) or Lp(a) is increasingly recognized as a significant, independent risk enhancer for cardiovascular disease (CVD). This course explores the evolving landscape of Lp(a) in clinical practice, emphasizing the importance of Lp(a) testing in comprehensive cardiovascular risk assessment. The safety and efficacy of current and emerging lipid-lowering therapies, with a focus on novel agents targeting Lp(a) reduction will be examined.
Claim CE and MOC credits: https://bit.ly/4r1xjU6
View all episodes
By American Heart Association
5
77 ratings
Elevated Lipoprotein(a) or Lp(a) is increasingly recognized as a significant, independent risk enhancer for cardiovascular disease (CVD). This course explores the evolving landscape of Lp(a) in clinical practice, emphasizing the importance of Lp(a) testing in comprehensive cardiovascular risk assessment. The safety and efficacy of current and emerging lipid-lowering therapies, with a focus on novel agents targeting Lp(a) reduction will be examined.
Claim CE and MOC credits: https://bit.ly/4r1xjU6
More shows like HeartBEATS from Lifelong Learning™
View all
The Curbsiders Internal Medicine Podcast
3,364 Listeners